Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Médica Electrónica
versión On-line ISSN 1684-1824
Resumen
RUFIN-GOMEZ, Lorenzo Ángel; MARTINEZ-MOREJON, Amancio; RUFIN-BERGADO, Ana Margarita y MENDEZ-MARTINEZ, Jesús. Metabolic syndrome: A factor of risk in patient of COVID-19. Rev.Med.Electrón. [online]. 2022, vol.44, n.1, pp. 142-154. Epub 28-Feb-2022. ISSN 1684-1824.
ABSTRACT
Metabolic syndrome comprises a set of cardiovascular risk factors tightly associated to obesity and insulin resistance that propitiates cardiovascular disease and type 2 diabetes mellitus. Its prevalence raises around the world, causing a pro-thrombotic and pro-inflammatory status which in the current context of the COVID-19 pandemic worsens the clinical characteristics of the patients. The objective was to analyze the current status of the scientific knowledge in the research on the interrelation between the metabolic disorders associated to proinflammatory condition, exacerbated in COVID-19 patients. Several combinations of descriptors were used in the review in PubMed, SciELO, Clinical Key and LILACS database, and the most recent articles were considered for the analysis and redaction. In the scientific literature a relevant role is attributed to the proinflammatory process that characterizes the metabolic syndrome manifestation as a risk factor, and in the complications in COVID-19 patients. The high and increasing prevalence worldwide of obesity, hypertension and type 2 diabetes mellitus-which are part of metabolic syndrome-indicates that they have not been given special attention; moreover, due to the inflammatory processes inherent in it and its lethal effects.
Palabras clave : metabolic syndrome; obesity, insulin resistance; inflammation; COVID-19.